Salivary Gland Cancers

2

Review clinical trials related to Salivary Gland Cancers. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

To learn if sacituzumab govitecan can help to control salivary gland cancer.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Patients ≥18 years with histology-proven R/M salivary gland cancer. [+15]

Prior radiation therapy (or other non-systemic therapy) within 2 weeks prior to... [+17]

Status: Recruiting

PDO Based Drug Sensitive Test in R/M SGC

To evaluate the consistency of drug efficacy between the clinical systemic treatment and drug sensitive test based on patient-derived organoid in R/M SGC patients, using a prospective and multicenter observational study to increase the generalizability and reliability of research conclusion.

Participants needed: 40
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Huashan HospitalUpdated: Sep 3, 2025Locations: 2Duration: 2 Years
Eligibility criteria

Pathologically confirmed R/M SGC patients [+5]

Metastatic tumors in the head and neck region, or non-salivary gland cancer tumo... [+8]